Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

ATRenew sees Q2 2025 Revenues between RMB4.710B and RMB4.810B, a 24.7% to 27.4% increase YoY

Author: Benzinga Newsdesk | May 20, 2025 04:21am

ATRenew (NYSE:RERE) sees Q2 sales of $649.055 million-$662.836 million vs $4.98 billion analyst estimate.

Posted In: RERE